article Open AccessTop 10% cited

Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine

Molecular Pharmacology · 2000 · Vol. 57(1) · pp. 75–81

Lawrence W. Fitzgerald✉(Experimental Station)Timothy C. Burn(MACOM (United States))Barry S. Brown(MACOM (United States))John P. Patterson(MACOM (United States))Martha H. Corjay(MACOM (United States))Patricia A. Valentine(MACOM (United States))Jung‐Hui Sun(MACOM (United States))John R. Link(MACOM (United States))Ilgar Abbaszade(MACOM (United States))Jeannine M. Hollis(MACOM (United States))Brian L. Largent(MACOM (United States))Paul Hartig(MACOM (United States))Gregory Hollis(MACOM (United States))Paul C. Meunier(MACOM (United States))Albert J. Robichaud(MACOM (United States))David W. Robertson(MACOM (United States))

View via DOI Publisher page

Pharmacology and Obesity Treatment Cyclopropane Reaction MechanismsReceptorFenfluramineDexfenfluramineMethysergide5-HT receptorSerotoninEndocrinologyInternal medicineChemistryStimulation

MeSH terms

AnimalsAppetite DepressantsCell LineFenfluramineHeart Valve DiseasesHeart ValvesHumansMolecular Sequence DataNorfenfluramineReceptors, SerotoninRNA, MessengerSwineSerotonin AgentsReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2B

Citations

428

FWCI

12.48

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Molecular, pharmacological and functional diversity of 5-HT receptors